Merck KGaA gets FDA warning letter on EU plants; Sandoz nabs German rights to ED med;

@FiercePharma: Yet another Ben Venue fumble: Sanofi's Genzyme unit recalls leukemia drug made at Ohio plant--Bloomberg. News | Follow @FiercePharma

> The FDA has warned Merck KGaA on manufacturing failures at three separate facilities--two in Switzerland and the other in Italy--based on inspections conducted last summer. Report | Letter

> Novartis' ($NVS) Sandoz unit snapped up German marketing rights to the Apricus Biosciences erectile dysfunction drug Vitaros. News

> Canada's Paladin Labs reported higher profits for the fourth quarter, fueled by increased sales of several drugs, including the Plan B contraceptive. Article

> Actavis launched its version of the Alzheimer's drug Aricept in 8 of the EU's biggest markets, including Germany and France, as the drug's patent protection expired. Release

> A Harvard College activist group demonstrated at Merck's ($MRK) Cambridge research labs in an effort to persuade the drugmaker to join the Medicines Patent Pool for HIV drugs. Report

> GlaxoSmithKline's ($GSK) unit in India saw profits grow more than 18% for the quarter on growth in its specialty products and vaccines. Story

> GlaxoSmithKline has met vocal opposition to its plans for two wind turbines that would help power its site in Montrose, Scotland. News

> Teva Pharmaceutical Industries ($TEVA) CEO Shlomo Yanai said the company has contingency plans for Israeli manufacturing if "regional issues" caused disruption. Report

> Teva launched its version of the Alzheimer's drug Aricept in the U.K. as Eisai's patent on the treatment expires in that market. Article

Biotech News

@FierceBiotech: Researchers soup up patients' own immune cells to attack HIV. Story | Follow @FierceBiotech

@JohnCFierce: Fledgling Mnemosyne Pharmaceuticals snags a $5.4 million Series A for neuropsychiatric work. Release | Follow @JohnCFierce

@RyanMFierce: Not for those with arachnophobia: J&J to develop painkillers with spider venom in the mix. Article | Follow @RyanMFierce

@FierceMedDev: Edwards has received CE Mark for its EDWARDS INTUITY for those undergoing surgical aortic valve replacement. Release | Follow @FierceMedDev

> Bionor surges as PhIIb study revives big hopes for HIV vaccine. News

> J&J backs potential pain drugs derived from spider venom. Item

> Biotech startup Mnemosyne snags $5.4M A round for neuropsych R&D. Article

Vaccines News

> FDA says no to Novartis' Menveo vax for babies. Article

> Gynecological cancer vaccine enters clinical trials. More

> Research paving way to salmonella vaccine. Story

> IIL developing firsts for vaccines in India. News

> Sanofi's Shantha Biotechnics hopes to relaunch vaccine. Item

Manufacturing News

> Hospira sees dim light at end of plant troubles. Piece

> FDA inspects three Merck plants along EU supply chain. Item

CRO News

> Complete Genomics soars after it snags sequencing deal with Mayo Clinic. Story

> Charles River sees signs of growth in latest assessment. More

> Quintiles to offer guidance on navigating Asian drug projects. News

> Ockham adds international oncology CRO ops in Nexus buyout. Article

> Report: Catalent wants $400M loan to back Aptuit unit buyout. Item

And Finally... Will resistant gonorrhea be the last push U.S. officials need to incentivize antibiotics development? Report